Carbon Monoxide Diffusing Capacity Predicts Cardiac Readmission in Patients Undergoing Left Ventricular Assist Device...

Area of Science:

• Cardiology
• Pulmonary Medicine
• Medical Devices

Background:

• Carbon monoxide diffusion capacity (DLCO) is often reduced in heart failure.
• The clinical significance of DLCO in patients receiving left ventricular assist devices (LVADs) is not well understood.
• LVADs are crucial for end-stage heart failure management.

Purpose of the Study:

• To investigate the predictive value of preoperative DLCO for survival and cardiac readmission rates in patients undergoing LVAD implantation.
• To assess the relationship between DLCO and postoperative pulmonary vascular resistance (PVR).

Main Methods:

• Retrospective analysis of 76 patients receiving continuous-flow LVADs as bridge-to-transplant.
• Patients underwent pulmonary function tests preoperatively.
• Stratification into low (<80% predicted DLCO) and high (≥80% predicted DLCO) groups.
• Primary endpoints: all-cause mortality and cardiac readmission (heart failure or arrhythmia).

Main Results:

• No significant difference in mortality between low and high DLCO groups.
• The low DLCO group exhibited significantly higher postoperative PVR.
• Two-year cardiac readmission rates were 33.5% for the low DLCO group versus 8.7% for the high DLCO group (P=0.028).
• Preoperative DLCO independently predicted cardiac readmission (HR: 4.32; P=0.005).

Conclusions:

• Low preoperative DLCO is a risk factor for cardiac readmission after LVAD implantation.
• Reduced DLCO is associated with increased postoperative PVR.
• DLCO assessment may aid in risk stratification for LVAD patients.